Costa Rica vs South Asia (IDA & IBRD): Immunization, HepB3
Costa Rica
99.0%
in 2024
South Asia (IDA & IBRD)
94.5%
in 2024
Costa Rica rank
1st
South Asia (IDA & IBRD) rank
1st
Immunization, HepB3 over time
- Costa Rica
- South Asia (IDA & IBRD)
How they compare
Costa Rica currently reports 99.0% against 94.5% in South Asia (IDA & IBRD), a difference of 4.5%.
Across all 28 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 1st and South Asia (IDA & IBRD) ranks 1st of 188 countries.
Costa Rica has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Costa Rica | South Asia (IDA & IBRD) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 81.7% | 0.1% | 81.6% | Costa Rica |
| 2000s | 88.1% | 14.4% | 73.7% | Costa Rica |
| 2010s | 92.7% | 77.2% | 15.5% | Costa Rica |
| 2020s | 93.8% | 90.6% | 3.2% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Costa Rica or South Asia (IDA & IBRD)?
- Costa Rica, at 99.0% against 94.5% in South Asia (IDA & IBRD) as of 2024.
- What is the difference in immunization, hepb3 between Costa Rica and South Asia (IDA & IBRD)?
- 4.5%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and South Asia (IDA & IBRD)?
- 28 years are reported by both, from 1997 to 2024.
- How do Costa Rica and South Asia (IDA & IBRD) rank globally for immunization, hepb3?
- Costa Rica ranks 1st and South Asia (IDA & IBRD) ranks 1st of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.